Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients

Transplantation

Volumn 61, Issue 8, 1996, Pages 1268-1272

  Osowski, Cynthia L ^a   Dix, Suzanne P ^a   Lin, Lillian S ^a   Mullins, Richard E ^a   Geller, Robert B ^a   Wingard, John R ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FLUCONAZOLE; TACROLIMUS;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG POTENTIATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STEADY STATE;

ANTIFUNGAL AGENTS; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; DRUG INTERACTIONS; FLUCONAZOLE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029913912     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604270-00026     Document Type: Article

References (17)

1. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845.
2. Canafax DM, Graves NM, Hilligoss DM, et al. Interaction between cyclosporine and fluconazole in renal allograft recipients. Transplantation 1991; 51: 1014.
3. Lopez-Gil JA. Fluconazole-cyclosporine interaction: a dose-dependent effect? Ann Pharmacother 1993; 27: 427.
4. Lazar JD, Wilner KD. Drug interactions with fluconazole. Rev Infect Dis 1990; 12: S327.
5. Kruger HU, Schuler U, Zimmermann R, et al. Absence of significant interaction of fluconazole with cyclosporin. J Antimicrob Chemother 1989; 24: 781.
6. Manez R, Martin M, Raman V, et al. Fluconazole therapy in transplant recipients receiving FK506. Transplantation 1994; 57: 1521.
7. Kennedy MS, Yee GC, McGuire TR, et al. Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients. Transplant Proc 1985; 14(suppl 1): 196.
8. Backman L, Nicar M, Levy M, et al. FK506 trough levels in whole blood and plasma in liver transplant recipients. Transplantation 1994; 57: 519.
9. Sandoz Pharmaceuticals Corporation. Cyclosporine product information. East Hanover, NJ, 1994.
10. Fujisawa USA Inc. Tacrolimus product information. Deerfield, IL, 1994.
11. TDx immunosuppressant drug assays: cyclosporine monoclonal whole blood. Abbott Laboratories, Abbott Park, IL, 1993.
12. IMx tacrolimus assay. Abbott Laboratories, Diagnostics Division, Abbott Park, IL, 1993.
13. Wallace JE, Harris SC, Gallegos J, et al. Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column. Antimicrob Agents Chemother 1992; 36: 603.
14. Roerig, Division of Pfizer, Inc. Fluconazole product information. New York, NY. 1994.
15. Lehmann EL. Nonparametrics: statistical methods based on ranks. Oakland, CA: Holden-Day, 1975.
16. Tukey JW. Exploratory data analysis. Reading, MA: Addison-Wesley, 1977.
17. Watkins PB. Role of cytochromes P450 in drug metabolism and hepatotoxicity. Semin Liver Dis 1990; 10: 235.